UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 37

Sortiert nach

Staphylococcus haemolyticus meningitis and bacteremia in an allogenic stem cell transplant patient

IDCases, 2021-01, Vol.26, p.e01259, Article e01259

2021

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic haematopoietic stem‐cell transplantation for relapsed and refractory aggressive histology non‐Hodgkin lymphoma

British journal of haematology, 2005-10, Vol.131 (2), p.223-230

2005

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic haematopoietic cell transplant services in Australia and New Zealand in the first year of the COVID‐19 pandemic: A report from Australia and New Zealand Transplant and Cellular Therapies

Internal medicine journal, 2022-07

2022

Link zum Volltext

Verfügbarkeit prüfen

The association of socioeconomic deprivation with access and survival after hematopoietic stem cell transplantation in New Zealand

Asia-Pacific journal of clinical oncology, 2023-04, Vol.19 (2), p.e89-e95

2023

Link zum Volltext

Verfügbarkeit prüfen

Peripheral Blood Haploidentical Allogeneic Stem Cell Transplantation in Older Adults with AML/MDS Demonstrates Excellent Long Term Overall Survival, Results from the Australasian Bone Marrow Transplant Recipient Registry

Blood, 2021-11, Vol.138 (Supplement 1), p.2929-2929

2021

Link zum Volltext

Verfügbarkeit prüfen

Misquotation

Internal medicine journal, 2017-03, Vol.47 (3), p.344-344

2017

Link zum Volltext

Verfügbarkeit prüfen

Treatment outcomes of patients with acute promyelocytic leukaemia between 2000 and 2017, a retrospective, single centre experience

Leukemia research, 2020-06, Vol.93, p.106358-106358, Article 106358

2020

Link zum Volltext

Verfügbarkeit prüfen

Early treatment of acute promyelocytic leukaemia is accurately guided by the PML protein localisation pattern: real-life experience from a tertiary New Zealand centre

Pathology, 2019-06, Vol.51 (4), p.412-420

2019

Link zum Volltext

Verfügbarkeit prüfen

Bone Marrow Transplant Society of Australia and New Zealand COVID‐19 consensus position statement

Internal medicine journal, 2020-06, Vol.50 (6), p.774-775

2020

Link zum Volltext

Verfügbarkeit prüfen

Peripheral Blood Haploidentical Allogeneic Stem Cell Transplantation in Older Adults with Acute Myeloid Leukemia and Myelodysplastic Syndromes Demonstrates Long Term Survival, Results from Australia and New Zealand Transplant and Cellular Therapies

Transplantation and cellular therapy, 2024-03, Vol.30 (3), p.334.e1-334.e7

2024

Link zum Volltext

Verfügbarkeit prüfen

Incidence of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease and Treatment with Defibrotide in Allogeneic Transplantation: A Multicenter Australasian Registry Study

Transplantation and cellular therapy, 2023-06, Vol.29 (6), p.383.e1-383.e10

2023

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic Haematopoietic Cell Transplantation for Mantle Cell Lymphoma Can Achieve Durable Remission and Myeloablative Conditioning Is Associated with Inferior Survival: An Australasian Bone Marrow Transplant Recipient Registry Study

Transplantation and cellular therapy, 2021-03, Vol.27 (3), p.S394-S395

2021

Link zum Volltext

Verfügbarkeit prüfen

Improvement in Non-Relapse Mortality Following Allogeneic Transplantation for Chronic Lymphocytic Leukaemia in Australia and New Zealand: An Australasian Bone Marrow Transplant Recipient Registry Study

Transplantation and cellular therapy, 2021-03, Vol.27 (3), p.S133-S135

2021

Link zum Volltext

Verfügbarkeit prüfen

A Retrospective Analysis of 344 Fludarabine Melphalan RIC Allogeneic Stem Cell Transplants for Myeloid and Lymphoid Malignancies In Australia and New Zealand 1998–2008

Blood, 2011-11, Vol.118 (21), p.4143-4143

2011

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic hematopoietic cell transplant for multiple myeloma using reduced intensity conditioning therapy, 1998-2006: factors associated with improved survival outcome

Leukemia & lymphoma, 2011-09, Vol.52 (9), p.1727-1735

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(35)
Berichte
(2)

Sprache

Englisch
(37)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(16)
Science & Technology
(16)
Humans
(14)
Hematology
(9)
Adult
(8)
Female
(7)
General & Internal Medicine
(6)
Medicine, General & Internal
(6)
Male
(5)
New Zealand - Epidemiology
(5)
Covid-19
(4)
Hematopoietic Stem Cell Transplantation - Adverse Effects
(4)
Middle Aged
(4)
New Zealand
(4)
Oncology
(4)
Transplantation, Homologous
(4)
Adolescent
(3)
Aged
(3)
Australia
(3)
Child
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Staphylococcus haemolyticus meningitis and bacteremia in an allogenic stem cell transplant patient

Allogeneic haematopoietic stem‐cell transplantation for relapsed and refractory aggressive histology non‐Hodgkin lymphoma

Allogeneic haematopoietic cell transplant services in Australia and New Zealand in the first year of the COVID‐19 pandemic: A report from Australia and New Zealand Transplant and Cellular Therapies

The association of socioeconomic deprivation with access and survival after hematopoietic stem cell transplantation in New Zealand

Peripheral Blood Haploidentical Allogeneic Stem Cell Transplantation in Older Adults with AML/MDS Demonstrates Excellent Long Term Overall Survival, Results from the Australasian Bone Marrow Transplant Recipient Registry

Allogeneic Stem Cell Transplantation for Mantle Cell Lymphoma Can Achieve Durable Remission and Myeloablative Conditioning Is Associated with Inferior Survival: An Australasian Bone Marrow Transplant Recipient Registry Study

Misquotation

Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID‐19 pandemic

An Australasian Bone Marrow Transplant Registry (ABMTR) Study of the Trends and Outcomes of Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) in Hodgkin Lymphoma between 2009-2019: Relapse Remains the Most Common Cause of Death Post Transplantation

Improvement in Non-Relapse Mortality Following Allogeneic Transplantation for Chronic Lymphocytic Leukaemia in Australia and New Zealand: An Australasian Bone Marrow Transplant Recipient Registry Study

Allogeneic Stem Cell Transplantation for Diffuse Large B Cell Lymphoma Can Achieve Durable Remissions: An Australasian Bone Marrow Transplant Recipient Registry Study

Treatment outcomes of patients with acute promyelocytic leukaemia between 2000 and 2017, a retrospective, single centre experience

Australia and New Zealand Transplant and Cellular Therapies (ANZTCT) position statement: COVID‐19 management in patients with haemopoietic stem cell transplant and chimeric antigen receptor T cell

Australia and New Zealand Transplant and Cellular Therapies COVID‐19 vaccination consensus position statement

Early treatment of acute promyelocytic leukaemia is accurately guided by the PML protein localisation pattern: real-life experience from a tertiary New Zealand centre

Bone Marrow Transplant Society of Australia and New Zealand COVID‐19 consensus position statement

Peripheral Blood Haploidentical Allogeneic Stem Cell Transplantation in Older Adults with Acute Myeloid Leukemia and Myelodysplastic Syndromes Demonstrates Long Term Survival, Results from Australia and New Zealand Transplant and Cellular Therapies

Incidence of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease and Treatment with Defibrotide in Allogeneic Transplantation: A Multicenter Australasian Registry Study

CD56 bright natural killer regulatory cells in filgrastim primed donor blood or marrow products regulate chronic graft- versus -host disease: the Canadian Blood and Marrow Transplant Group randomized 0601 study results

Allogeneic Haematopoietic Cell Transplantation for Mantle Cell Lymphoma Can Achieve Durable Remission and Myeloablative Conditioning Is Associated with Inferior Survival: An Australasian Bone Marrow Transplant Recipient Registry Study

Allogeneic Stem Cell Transplantation for Diffuse Large B Cell Lymphoma Can Achieve Durable Remissions: An Australasian Bone Marrow Transplant Recipient Registry Study

Improvement in Non-Relapse Mortality Following Allogeneic Transplantation for Chronic Lymphocytic Leukaemia in Australia and New Zealand: An Australasian Bone Marrow Transplant Recipient Registry Study

A Canadian Blood and Marrow Transplant Group (CBMTG) Randomised Trial Comparing G-CSF Mobilized Peripheral Blood Versus G-CSF Stimulated Bone Marrow In Recipients Of Sibling Allografts For Hematologic Malignancies

A Retrospective Analysis of 344 Fludarabine Melphalan RIC Allogeneic Stem Cell Transplants for Myeloid and Lymphoid Malignancies In Australia and New Zealand 1998–2008

Allogeneic hematopoietic cell transplant for multiple myeloma using reduced intensity conditioning therapy, 1998-2006: factors associated with improved survival outcome

Suchergebnisse filtern